Skip to main content

Find Clinical Trials

Home
Conditions
RNA Virus Infections

Clinical trial condition

RNA Virus Infections

Explore clinical trials studying RNA Virus Infections. Study availability and eligibility vary by location and protocol.

81 public trials 4 recruiting studies

Refine in advanced search Browse all conditions

RNA Virus Infections trial results

Completed

Centralized Reminder Recall - Flu RCT2

NCT03294473

Conditions: Infections, Influenza, Human, Orthomyxoviridae Infections, +8 more
Locations: University of California, Los Angeles Los Angeles, California, United States

View Trial Details

Completed

Efficacy and Safety of Sofosbuvir/Velpatasvir ± Ribavirin for 12 Weeks in Adults With Chronic HCV Infection and Decompensated Cirrhosis

NCT02996682

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +12 more
Locations: Shimonoseki, Yamaguchi, Japan

Bunkyō City, Japan

Chiba, Japan

Chūō, Japan

View all 33 locations

View Trial Details

Completed

Active Surveillance for Adverse Events Following Immunization With the Butantan Trivalent Influenza Vaccine (2018)

NCT03392207

Conditions: Infections, Influenza, Human, Orthomyxoviridae Infections, +6 more
Locations: Crie - Unifesp São Paulo, Brazil

Avenida Vital Brasil 1500 São Paulo, Brazil

View Trial Details

Completed

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination Administered in Patients Infected With Chronic Genotype 1 or 4 HCV for Use in the Peri-Operative Liver Transplantation Setting

NCT02350569

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +12 more
Locations: San Francisco, California, United States

Chicago, Illinois, United States

New Orleans, Louisiana, United States

Detroit, Michigan, United States

View Trial Details

Completed

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin for the Treatment of HCV (ION-3)

NCT01851330

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C Virus, +17 more
Locations: Birmingham, Alabama, United States

La Jolla, California, United States

Los Angeles, California, United States

Palo Alto, California, United States

View all 52 locations

View Trial Details

Completed

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin in Treatment-Experienced Subjects With Genotype 1 HCV Infection

NCT01768286

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C Virus, +17 more
Locations: Phoenix, Arizona, United States

Tucson, Arizona, United States

La Jolla, California, United States

Los Angeles, California, United States

View all 53 locations

View Trial Details

Completed

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination (FDC) With and Without Ribavirin for the Treatment of HCV

NCT01701401

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C Virus, +17 more
Locations: Birmingham, Alabama, United States

La Jolla, California, United States

Long Beach, California, United States

Los Angeles, California, United States

View all 88 locations

View Trial Details

Completed

Rapid Hepatitis C Elimination Trial- A Pilot Study of Daclatasvir/Asunaprevir/BMS-791325 With or Without Ribavirin To Treat Hepatitis C Virus

NCT02098616

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: VA Long Beach Healthcare System Long Beach, California, United States

View Trial Details

Completed

Clinical Immunization Safety Assessment (CISA) Project: Pilot Study to Assess the Effect of Prophylactic Antipyretics on Immune Responses and Fever After IIV

NCT01946594

Conditions: Body Temperature Changes, Fever, Infections, +8 more
Locations: Duke University Health System Durham, North Carolina, United States

View Trial Details

Completed

Feasibility of Measuring Immune Resp, Activation in Foreskin/Mucosa in HIV-, Uncircumcised High-HIV-risk MSM, Lima Peru

NCT02630082

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +16 more
Locations: Not specified

View Trial Details